cns10-npc-gdnf
Cell therapyexperimental
Clinical trial activity
2 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Apr 1, 2017 (NCT02943850)
Timeline
2010s
- Jan 1, 2017
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- AstrocytesSupplementation
supplementation - astrocytes
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- cns10-npc-gdnf
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05306457 | Phase 1 | Apr 30, 2022 | California Institute for Regenerative Medicine (CIRM), Cedars-Sinai Medical Center |
| NCT02943850 | Phase 1 | Apr 1, 2017 | California Institute for Regenerative Medicine, Cedars-Sinai Medical Center |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Cedars-Sinai Medical Center | Academic/Hospital | 2 | 2 | 1 | 2017 |
| California Institute for Regenerative Medicine | Academic/Hospital | 1 | 0 | 1 | 2017 |
| California Institute for Regenerative Medicine (CIRM) | Academic/Hospital | 1 | 0 | 1 | 2022 |
3 organizations
Page 1 / 1